Purpose: The purpose of this study was to determine whether excessive polypharmacy is associated with a higher survival rate in polypathological patients.
Patients And Methods: An observational, prospective, and multicenter study was carried out on those polypathological patients admitted to the internal medicine and acute geriatrics departments between March 1 and June 30, 2011. For each patient, data concerning age, sex, comorbidity, Barthel and Lawton-Brody indexes, Pfeiffer's questionnaire, socio-familial Gijon scale, delirium, number of drugs, and number of admissions during the previous year were gathered, and the PROFUND index was calculated. Polypharmacy was defined as the use of ≥ 5 drugs and excessive polypharmacy as the use of ≥ 10. A 1-year long follow-up was carried out. A logistic regression model was performed to analyze the association of variables with excessive polypharmacy and a Cox proportional hazard model to determine the association between polypharmacy and survival.
Results: We included 457 polypathological patients. Mean age was 81.0 (8.8) years and 54.5% were women. The mean number of drugs used was 8.2 (3.4). Excessive polypharmacy was directly associated with heart disease [hazard ratio (HR) 2.33 95% CI 1.40-3.87; p =0.001], respiratory disease [HR 1.87 95% CI 1.13-3.09; p = 0.01], peripheral artery disease/diabetes with retinopathy and/or neuropathy [HR 2.02 95% CI 1.17-3.50; p = 0.01], and the number of admissions during the previous year [HR 1.21 96%CI 1.01-1.44; p = 0.04]. It was inversely associated with delirium [HR 0.48 95% CI 0.25-0.91; p = 0.02]. There were no statistical differences regarding the probability of 1-year survival between patients with no polypharmacy, with simple polypharmacy, and with excessive polypharmacy (0.66, 0.60, and 0.57, respectively, p = 0.12).
Conclusions: A greater use of drugs may not be harmful but is also not associated with a higher probability of survival in polypathological patients.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s00228-015-1837-8 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Clinical Manifestations.
Alzheimers Dement
December 2024
Neurocognitive Unit, Division of Neurology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Background: Behavioral and psychological symptoms of dementia (BPSD) profoundly impact individuals with dementia and their caregivers. Despite existing pharmacological interventions, symptom control remains challenging, often prompting polypharmacy with potential risks. Notably, in clinical practice, caregivers frequently report recurring patterns in patients' BPSD but lack empirical studies supporting these observations.
View Article and Find Full Text PDFPolypharmacy or potentially inappropriate medications among older adults with COVID-19 in a secondary hospital in China and their association with mortality.
Sci Rep
January 2025
Department of Pharmacy, Shanghai Gonghui Hospital, Shanghai, People's Republic of China.
Elderly patients with multiple concomitant chronic diseases are the particularly vulnerable during the Coronavirus disease 2019 (COVID-19) epidemic, which accounts for a large number of COVID-19-related deaths. The purpose of the study was to investigate the impact of polypharmacy and potentially inappropriate medications (PIMs) on in-hospital mortality in a secondary hospital in China. A cross-sectional, retrospective study was conducted using electronic medical data collected from Shanghai Gonghui Hospital from April 2022 to June 2022.
View Article and Find Full Text PDFOutpatient Management of Bipolar Disorder in Older Adults.
Curr Psychiatry Rep
December 2024
Department of Psychiatry and Behavioral Sciences, Dell Medical School, The University of Texas at Austin, AMG Seton Behavioral Health, 1301 W. 38th Street, Suite 700, Austin, TX, 78757, USA.
Article Synopsis
- Older adults with bipolar disorder (OABD) face unique challenges in diagnosis and treatment, particularly in outpatient settings.
- Mood episodes in OABD are similar in frequency and severity to those in younger adults, with depression being more common and mixed symptoms frequent.
- Effective treatment may involve using lower doses of lithium over other medications, and clinicians should focus on managing medical comorbidities and reducing the number of medications prescribed.
Drug prescriptions in elderly hospitalized patients with cognitive impairment in the Italian Dementia Friendly Hospital project.
Front Pharmacol
November 2024
Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.
Objective: The aim of the study was to characterize drug prescription patterns in elderly patients hospitalized in acute wards as a function of cognitive status and staff training.
Methods: We recorded clinical parameters reflecting health status and drug prescriptions at admission, during hospital stay, and at discharge before and after a short staff training on the needs of aged cognitively impaired patients. Participants aged 65 and older had a Mini-Mental State Examination (MMSE) score ≥16.
Use of Medications With Somnolence Adverse Effects and Somnolence Symptoms Among Older Adults in the U.S.
J Aging Health
November 2024
Program on Medicines and Public Health, University of Southern California Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, Los Angeles, CA, USA.
Objectives: Nearly half of older adults experience somnolence, but the link between medications with somnolence as an adverse effect and somnolence is unclear. This study investigated the association between polypharmacy and somnolence symptoms (excessive sleepiness or long sleep duration).
Methods: Data from the National Social Life, Health, and Aging Project (NSHAP) 2010-2011 was used to examine the concurrent use of medications with potential somnolence as an adverse effect and the prevalence of somnolence symptoms.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!